Kardigan, Inc. Common Stock (KARD)

Kardigan, Inc. Common Stock (KARD) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day +0.5%, 1 week -1.8%.

Kardigan, Inc. is a clinical-stage precision therapeutics company specializing in the development of treatments for underserved cardiovascular diseases.

Groups KARD belongs to

• Biotechnology
• Clinical Stage
• Recent IPOs
• Cardiovascular Therapies
• Clinical Stage Biotech
• Precision Medicine
• Healthcare
• Biopharmaceutical
• Unmet Medical Needs
• Rare Diseases

KARD financial model: income statement, cash flow and balance sheet